Moneycontrol
HomeNewsBusinessDespite setting aside 1 in 3 beds for COVID cases, Fortis Healthcare says occupancy, realisations are subdued
Trending Topics

Despite setting aside 1 in 3 beds for COVID cases, Fortis Healthcare says occupancy, realisations are subdued

Most Fortis hospitals are concentrated in Delhi NCR and Mumbai, where Covid cases are on the decline and price caps are in place. With elective surgeries getting postponed, restrictions on international travel, and limited lockdowns in select States, non-Covid realisations have also taken a hit

August 18, 2020 / 15:50 IST
Story continues below Advertisement

Fortis Healthcare, which has seen occupancy levels nosedive due to the sharp fall in elective surgeries, outpatient consultations and stoppage of international patients, has struggled to capture the Covid-19 opportunity. That, too, despite setting aside a major part of its infrastructure to treat patients afflicted by the disease.

The company says the reason for low realisations from Covid-19 is due to the price caps imposed by State governments and the declining trend of cases in the geographies that it operates in.

Story continues below Advertisement

Of the 3,650 operational beds in its network, Fortis Healthcare has currently allocated around 1,260 beds for Covid-19 patients.

Battered by COVID

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show